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Current concepts of the neurobiology of stress-related disorders, such as anxiety and
depression emphasize disruptions in neural plasticity and neurotrophins.The potent trophic
actions of exercise, therefore, represent not only an effective means for prevention and
treatment of these disorders, they also afford the opportunity to employ exercise paradigms
as a basic research tool to uncover the neurobiological mechanisms underlying these disor-
ders. Novel approaches to studying stress-related disorders focus increasingly on trophic
factor signaling in corticolimbic circuits that both mediate and regulate cognitive, behav-
ioral, and physiological responses to deleterious stress. Recent evidence demonstrates
that the neural plasticity supported by these trophic mechanisms is vital for establishing
and maintaining resilience to stress. Therapeutic interventions that promote these mech-
anisms, be they pharmacological, behavioral, or environmental, may therefore prevent or
reverse stress-related mental illness by enhancing resilience. The present paper will pro-
vide an overview of trophic mechanisms responsible for the enhancement of resilience
by voluntary exercise with an emphasis on brain-derived neurotrophic factor, galanin, and
interactions between these two trophic factors.
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TROPHIC MECHANISMS FOR EXERCISE-INDUCED STRESS
RESILIENCE: POTENTIAL ROLE OF INTERACTIONS BETWEEN
BDNF AND GALANIN
Clinical studies convincingly establish the efficacy of exercise in
the treatment of anxiety and affective disorders (1–3). However,
understanding the neurobiological mechanisms responsible for
these beneficial effects, a goal that necessitates the application of
rodent models, remains a challenge. Since deleterious stress lies at
the core of anxiety and depression, understanding the neurobio-
logical impacts of stress, and the mechanisms for adapting to it
will significantly enhance the development of more effective pre-
vention and treatment. Recent advances in exercise neuroscience
using rodent models have shed new light on the neural mecha-
nisms by which physical activity produces long-term adaptations
in brain circuits implicated in anxiety and depressive disorders.
This literature reveals that the most significant impact of exercise
on stress may not pertain to regulating transient states occur-
ring in the presence of the stressor, but rather on moderating the
long-term impact that acute stress may incur on subsequent stress
events. The key benefit of exercise may thus involve the promotion
of stress resilience.
The present paper will focus on stress resilience as a funda-
mental phenomenon underlying the beneficial effects of exercise,
and it will briefly review the neurotrophic hypothesis of stress
resilience. Two trophic mechanisms that may be involved in the
stress resilience will be examined; one involving the widely stud-
ied brain-derived neurotrophic factor (BDNF) system and another
based on the lesser-known trophic actions of the peptide galanin.
The purpose of this comparison will be to point out a critical
area for future investigation, which should aim to uncover how
different trophic mechanisms may interact to promote optimal
neural function.
EFFECTS OF EXERCISE IN RODENT MODELS OF DEPRESSION
AND ANXIETY AND THEIR IMPLICATIONS FOR STRESS
RESILIENCE
Though exercise represents an effective intervention for stress-
related disorders in humans, evidence for its antidepressant and
anxiolytic efficacy in rodent behavioral models is surprisingly
inconclusive. In recent, comprehensive reviews of the anxiolytic
and antidepressant effects of exercise in rodent models a common
theme emerges, in which that exercise produces mixed and con-
flicting effects in standard rodent tests of anxiety and depression
(4–6). Much of the conflicting evidence derives from the species or
strain used as subjects, duration, and mode of exercise employed
as the independent variable, and the selection of model that serves
as the dependent measure of depressive- or anxiety-like behavior.
Experiments employing forced modes of exercise, such as tread-
mill or swimming, introduce the confounding factor of stressor
exposure on subsequent measures of stress-related behavior and
are thus difficult to interpret. Furthermore, rodent paradigms that
putatively model depressive-like behavior are plagued by ques-
tions of validity, and the most widely employed “models,” such as
the forced swim or tail suspension tests, are better characterized
as bioassays or screens for pharmacological manipulations with
potential antidepressant activity (7). A particularly problematic
aspect of these models is that they are too often assumed to repre-
sent the chronic, self-perpetuating nature of major depression by
assessing a “snapshot” of spontaneous responsiveness to an acute
stressor when no predisposing factors have been manipulated.
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They also assume that antidepressant actions may be observed
in a healthy subject. It is with these caveats in mind that one
must cautiously interpret the reports that exercise may exert either
antidepressant-like, “pro-depressive,” or no effects in the forced
swim or similar tests (5, 8, 9).
Similar problems of interpretation arise when critically exam-
ining exercise effects in anxiety models. When such models are
applied as a single measure of spontaneous behavior in the pres-
ence of the mild stress associated with standard tests, it is diffi-
cult to ascertain whether increased responding reflects behavior
reminiscent of anxiety or, rather, adaptive coping to the exi-
gencies of the stressor. Both interpretations have been proposed
in previous studies, and exercise has been variously character-
ized that has anxiogenic, anxiolytic, or without effect (4–6).
This range of contradictory results is evident even when focus-
ing on a single model, the elevated plus-maze. After systemat-
ically reviewing this literature, we have proposed that under-
standing the effects of exercise hinge upon examination of the
longitudinal impact of stress exposure on subsequent respond-
ing (6). We have thus shown that the anxiolytic-like effects of
exercise are only consistently observed in standard models of
anxiety when rats have been previously exposed to a different
type of stressor. Exercise, thus appears to promote resilience to
stress.
TROPHIC MECHANISMS IN STRESS RESILIENCE
Emerging concepts of the neurobiology of stress-related disorders,
such as anxiety and depression emphasize disruptions in neural
plasticity and trophic mechanisms (10, 11). Current research on
the neurobiology of stress, thus, increasingly involves measures
of neurogenesis, dendritic arborization, dendritic spine mainte-
nance, synaptogenesis, and other forms of plasticity. This new
perspective on the neurobiological basis of anxiety and depressive
disorders is superseding traditional explanations that emphasize
dysfunction in monoaminergic transmission as the primary eti-
ological mechanism. The focus is thus shifting to the role of
disruptions in trophic factor signaling, especially in corticolim-
bic circuits that mediate and/or regulate cognitive, behavioral, and
physiological responses to stress. Recent evidence demonstrates
that the neural plasticity supported by these trophic mechanisms
is vital for establishing and maintaining stress resilience (12, 13).
Stress-induced atrophy of the hippocampus has been linked to
decreased resilience in clinical populations and rodent models
(11, 14–16). Maintenance of plasticity in the medial prefrontal
cortex (mPFC) also plays a crucial role in stress resilience, and
disturbances in this plasticity are linked to the pathophysiology of
depression and anxiety (17–21). The translational value of this new
perspective on trophic mechanisms will be the identification and
development of therapeutic interventions that enhance resilience-
promoting plasticity, be they pharmacological, behavioral, or
environmental.
ROLE OF EXERCISE-INDUCED REGULATION OF
HIPPOCAMPAL BDNF IN ANXIETY AND DEPRESSION
The prominence of trophic mechanisms in determining the patho-
physiology of anxiety and depression compels further examination
of the profound influence exercise exerts on trophic factor
expression. Much work already has demonstrated the capacity for
exercise to induce a variety of trophic factors in the brain and
periphery, such as BDNF, insulin-like growth factor (IGF-1), vas-
cular endothelial growth factor (VEGF), and the inflammatory
protein VGF (11), but most of this previous research has focused
on BDNF signaling in the hippocampus (11, 22–24).
Brain-derived neurotrophic factor is a member of the neu-
rotrophin family, a group of structurally related peptide growth
factors that signal through TrkB receptors (22). BDNF is directly
implicated in various forms of hippocampal plasticity induced
by exercise (25, 26), leading many researchers to hypothesize that
this action may mediate antidepressant and anxiolytic effects of
exercise (11, 15, 23). This hypothesis is supported by numerous
findings of relationships between exercise, BDNF, hippocampal
plasticity, and antidepressant actions. For example, exercise con-
sistently elevates BDNF expression in the hippocampus (23, 27,
28) and potentiates the antidepressant activity of antidepressant
drugs in the forced swim test [(9); though c.f. (8)]. Antidepres-
sant effects of exercise in mice are eliminated by BDNF knockout
and inhibition of MAPK signaling, an intracellular mediator of
BDNF (29). Exercise also reliably enhances hippocampal neu-
rogenesis (30). This evidence has provided the foundation for
the hypothesis that the beneficial effects of exercise are mediated
specifically by BDNF-induced neurogenesis in the hippocam-
pus. This hypothesis is an extension, what is generally referred
to as the “neurogenesis hypothesis of affective disorders.” Some
reports from the exercise literature support this hypothesis (11,
25), though systematic reviews of studies linking hippocampal
BDNF to antidepressant actions in humans and rodent models
found many disassociations between BDNF and depression (31,
32). With respect to neurogenesis specifically, exercise-induced
hippocampal neurogenesis is associated with increased sponta-
neous anxiety-like behavior, an effect that is reversed after irra-
diation, which effectively eliminates neurogenesis (33, 34). As
described above, the discrepancies in the literature may relate
to whether the behavioral paradigm measures acute stress reac-
tivity or the longitudinal impact of stress (i.e., resilience). They
may also depend on the nature of trophic factor-mediated plas-
ticity in the hippocampus. In addition to its neurogenic effects,
exercise induces other forms of plasticity in hippocampal neu-
rons, such as alterations in dendritic spine architecture (23), which
must be considered in accounting for antidepressant or anxiolytic
effects.
The studies presented above establish links between exercise,
BDNF, and antidepressant actions. However, whether BDNF-
dependent actions of exercise in the hippocampus reflect anti-
depressant effects per se or some underlying process such as
stress resilience is not clear. Hippocampal administration of
BDNF does not reverse the exaggerated stress response exhib-
ited by rats previously exposed to uncontrollable stress, and a
pharmacological manipulation that reduces hippocampal BDNF
does not exacerbate the effects of stress on subsequent stress
responses (35). These findings suggest that BDNF signaling in
the hippocampus does not have a generalized influence on stress
resilience.
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POTENTIAL ROLE OF EXERCISE-INDUCED REGULATION OF
LOCUS COERULEUS GALANIN IN STRESS RESILIENCE
As discussed above, exercise increases the expression of a
wide range of trophic factors throughout the brain. A fuller
understanding of how trophic mechanisms are involved in the
beneficial effects of exercise on stress-related behaviors, therefore,
requires expanding the scope beyond BDNF in the hippocampus
and examining other trophic systems. Galanin is a neuromod-
ulatory peptide and trophic factor that exerts multiple effects
through its interaction with specific G protein-coupled recep-
tor subtypes designated GalR1, GalR2, and GalR3 (36, 37). Both
galanin and its receptors are widely distributed in several brain
systems, and galanin signaling thus impacts a variety of cognitive,
behavioral, and endocrine functions. Some of the highest concen-
trations of galanin are found in the locus coeruleus (LC), where
galanin is colocalized in over 80% of noradrenergic neurons (38).
Galanin-containing LC neurons extensively innervate the mPFC,
where galanin-immunoreactive terminals and GalR2 receptors are
present in relatively high densities (39–41).
Research from my laboratory has repeatedly shown that 3 weeks
of voluntary exercise elevates galanin gene expression in the LC
in a running distance-dependent fashion (42–44). We have also
shown that exercise exerts antidepressant effects in chronic models
of depression (45), and chronic antidepressant treatment elevates
galanin mRNA in the LC similarly to exercise (46). This evidence
raises the obvious question of whether galanin exerts antidepres-
sant and/or anxiolytic effects. Reviews of the extensive literature on
the effects of galanin on anxiety- and depression-related behaviors
show that galanin’s effects on these behaviors, like those of exercise,
are mixed and conflicting (47). Most of these previous experi-
ments involved acute, central administration of galanin receptor
ligands with subsequent tests of spontaneous behavior in standard
models. With regard to galanin/GalR1/GalR2 transgenic mice, the
findings are even more conflicting with predominantly negative
findings in most standard anxiety and depression models (47).
Despite these confusing results, the behavioral evidence is
clearer in experiments that examined galanin’s influence on the
longitudinal impact of stress. For example Lu et al. (48) reported
no effect of GalR2 knockout on spontaneous behaviors such
as elevated plus-maze, light/dark transition, forced swim, or
tail suspension tests. However, GalR2 knock-out mice exhib-
ited increased susceptibility to the repeated stress employed in a
“learned helplessness”-like paradigm compared to wild type mice.
Unlike the other tests, “learned helplessness” paradigms exam-
ine the impact of uncontrollable stress exposure on subsequent
responding to repeated stressors. Loss of GalR2 led to a suscepti-
ble phenotype in this paradigm, suggesting that galanin signaling
through GalR2 is necessary for resilience. Further supporting a
specific role for GalR2 in resilience, transgenic overexpression
of GalR2 in several frontocortical areas, including mPFC, was
found to decrease immobility in a version of the forced swim
test that involved pre-exposure to swim stress on the previous day
(49). In contrast, GalR2 overexpression had no effect on elevated
plus-maze or novel open field exploration in mice not previously
exposed to stress. The behavioral literature thus points to func-
tions for galanin beyond neuromodulatory effects. Galanin and
GalR2 in particular, are evidently involved in protecting against
the lasting consequences of an acute stress event by diminishing
reactivity to subsequent stressors rather than by modulating reac-
tivity to the acute stress event itself. This long-term protection
suggests a role for galanin in the plasticity underlying resilience.
Galanin is well positioned as a trophic factor expressed in
high concentrations in the LC to modify neural architecture in
stress-responsive targets such as the mPFC. As described above,
maintenance of dendritic spines in the mPFC may provide a cel-
lular mechanism for resilience. Recent studies of galanin have
revealed specific actions on neurite dynamics mediated by acti-
vation of GalR2 (50, 51). GalR2-mediated activation of Gq/11
influences multiple downstream targets, which includes inhibition
of the RhoA GTPase. Galanin thus promotes neurite formation in
neuronal cultures through a pathway involving GalR2-mediated
inhibition of RhoA-ROCK signaling through LIMK, with subse-
quent activation of the actin-binding protein cofilin (51). Stress is
associated with excess activation of RhoA, which leads to a reduc-
tion in spine densities (52). GalR2-mediated inhibition of RhoA-
ROCK signaling thus provides a hypothetical mechanism for
galanin-mediated protection against stress-induced spine atrophy.
GalR2-signaling may also stabilize neurites via maintenance of
microtubule integrity by promoting aggregation of microtubule-
associated protein 2 (MAP2) and β-tubulin (53), a process that
may also involve inhibition of RhoA (54). These actions of galanin
represent candidate mechanisms for protection against dendritic
spine atrophy induced by stress.
POTENTIAL INTERACTIONS BETWEEN BDNF AND GALANIN
IN OPTIMIZING NEURONAL FUNCTION
Though BDNF and galanin share common neurotrophic func-
tions, focusing on how the systems interact provides a new
approach to understanding neural plasticity. Intracellular signal-
ing of BDNF and galanin converges in many pathways, but their
mutual influence on MAP2 may reflect complementary mech-
anisms to promote spine maintenance during the physiological
challenges imposed by stress at the cellular level. TrkB-mediated
BDNF signaling promotes the expression of MAP2 and micro-
tubule assembly (54), whereas GalR2-signaling may be more
involved in maintaining microtubule assemblies by inhibiting
MAP2 phosphorylation, as described above. The two trophic
systems may thus mutually maintain microtubule integrity, but
through distinct mechanisms. Conversely, BDNF and galanin sig-
naling pathways diverge in the area of coflin activation. Binding of
BDNF to TrkB activates a LIMK through a RAC1 pathway, which
ultimately leads to the inactivation of cofilin (54). That GalR2-
signaling leads to the activation of cofilin through inhibition
of LIMK suggests that BDNF and galanin may exert counter-
regulatory influences in their mutual function to promote spine
maintenance.
Counter–regulatory interactions between galanin and BDNF
are also evident at the systems level. Left unchecked, exercise-
induced elevations in BDNF may lead to state of neuronal hyper-
excitability (22). Exercise induces a long-term enhancement of
glutamatergic activity through upregulation of NMDA recep-
tors (30). Additionally, enhanced transmission through AMPA
receptors promotes Ca++-mediated BDNF release and signaling
through TrkB (11, 54). The resulting BDNF-mediated effects on
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synaptic plasticity may further enhance excitatory glutamatergic
transmission. This positive feedback loop between BDNF and glu-
tamatergic activities accounts for the increased seizure vulnerabil-
ity and excitotoxicity seen following experimental manipulations
that enhance BDNF function, particularly in the hippocampus
(55–57). This potential state of hyperexcitability following BDNF
upregulation may also account for the finding of increased vul-
nerability to kainic acid-induced excitotoxicity following direct
injection into the hippocampus of anesthetized rats that had
undergone several weeks of exercise (58). In contrast to this find-
ing in anesthetized rats, we have shown decreased vulnerability
to kainic acid-induced seizures in awake, freely behaving rats
(59). The galanin receptor antagonist M40 blocked this exercise-
induced protection against seizures. Taken together, the evidence
suggests that under normal physiological conditions, the potential
state of hippocampal hyperexcitability induced by elevated BDNF
may be regulated by the galanin system. The anticonvulsant and
neuroprotective properties of both endogenous and exogenous
galanin are well established (50, 60, 61). The dense innervation
of the hippocampus by galaninergic projections originating from
the LC (62), the presence of galanin receptors in this structure
(63), and the increase in galanin with exercise (42–44), all point to
this system as a regulatory mechanism controlling the deleterious
consequences of exercise-induced upregulation of BDNF.
CONCLUSION
The trophic influences of exercise, which are mediated by a wide
range of neural and humoral factors, are well known. This body of
knowledge fits well with new concepts of anxiety and depression as
they relate to disturbances in neuroplasticity, and it reveals a com-
pelling neurobiological mechanism that explains the beneficial
effects of exercise on stress-related disorders. The literature from
rodent models suggests that the primary benefit of exercise may be
the promotion of resilience to stress. The translational value of this
hypothesis may be realized through the promotion of exercise as a
means to mitigate the longitudinal and cumulative impact of the
repeated stressors. Exercise may thus afford both preventative and
therapeutic benefits. Given the array of neurotrophins influenced
by exercise, the next challenge for future research will be to exam-
ine how these varied mechanisms coordinate to optimize neuronal
health. The interactions between BDNF and galanin represent an
informative example of how trophic mechanisms that mutually
promote the maintenance and survival of neurons may require
reciprocal regulatory influences to achieve their ultimate benefit.
REFERENCES
1. Cooney G, Dwan K, Greig C, Lawlor D, Rimer J, Waugh F, et al. Exercise
for depression. Cochrane Database Syst Rev (2013) 9:CD004366. doi:10.1002/
14651858.CD004366.pub6
2. Dunn AL,Trivedi MH,Kampert JB,Clark CG,Chambliss HO. Exercise treatment
for depression: efficacy and dose response. Am J Prev Med (2005) 28(1):1–8.
doi:10.1016/j.amepre.2004.09.003
3. Herring MP, O’Connor PJ, Dishman RK. The effect of exercise training on anx-
iety symptoms among patients: a systematic review. Arch Intern Med (2010)
170:321–31. doi:10.1001/archinternmed.2009.530
4. Greenwood B, Fleshner M. Exercise, learned helplessness, and the stress-
resistant brain. Neuromolecular Med (2008) 10(2):81–98. doi:10.1007/s12017-
008-8029-y
5. Novak C, Burghardt P, Levine J. The use of a running wheel to measure activity
in rodents: relationship to energy balance, general activity, and reward. Neurosci
Biobehav Rev (2012) 36(3):1001–14. doi:10.1016/j.neubiorev.2011.12.012
6. Sciolino NR, Holmes PV. Exercise offers anxiolytic potential: a role for stress and
brain noradrenergic-galaninergic mechanisms. Neurosci Biobehav Rev (2012)
36:1965–84. doi:10.1016/j.neubiorev.2012.06.005
7. Holmes PV. Rodent models of depression: reexamining validity without
anthropomorphic inference. Crit Rev Neurobiol (2003) 15:143–74. doi:10.1615/
CritRevNeurobiol.v15.i2.30
8. Arunrut T, Alejandre H, Chen M, Cha J, Russo-Neustadt A. Differential
behavioral and neurochemical effects of exercise, reboxetine and citalopram
with the forced swim test. Life Sci (2009) 84(17–18):584–9. doi:10.1016/j.lfs.
2009.02.005
9. Russo-Neustadt A, Ha T, Ramirez R, Kesslak J. Physical activity-antidepressant
treatment combination: impact on brain-derived neurotrophic factor and
behavior in an animal model. Behav Brain Res (2001) 120(1):87–95. doi:10.
1016/S0166-4328(00)00364-8
10. Duman R, Aghajanian G. Synaptic dysfunction in depression: potential thera-
peutic targets. Science (2012) 338(6103):68–72. doi:10.1126/science.1222939
11. Ota K, Duman R. Environmental and pharmacological modulations of cellular
plasticity: role in the pathophysiology and treatment of depression. Neurobiol
Dis (2013) 57:28–37. doi:10.1016/j.nbd.2012.05.022
12. Lehmann M, Herkenham M. Environmental enrichment confers stress resiliency
to social defeat through an infralimbic cortex-dependent neuroanatomical path-
way. J Neurosci (2011) 31(16):6159–73. doi:10.1523/JNEUROSCI.0577-11.2011
13. Amat J, Baratta M, Paul E, Bland S, Watkins L, Maier S. Medial prefrontal cor-
tex determines how stressor controllability affects behavior and dorsal raphe
nucleus. Nat Neurosci (2005) 8(3):365–71. doi:10.1038/nn1399
14. Alleva E, Francia N. Psychiatric vulnerability: suggestions from animal mod-
els and role of neurotrophins. Neurosci Biobehav Rev (2009) 33(4):525–36.
doi:10.1016/j.neubiorev.2008.09.004
15. Duman R, Monteggia L. A neurotrophic model for stress-related mood
disorders. Biol Psychiatry (2006) 59(12):1116–27. doi:10.1016/j.biopsych.2006.
02.013
16. McEwen B. Physiology and neurobiology of stress and adaptation: central role
of the brain. Physiol Rev (2007) 87(3):873–904. doi:10.1152/physrev.00041.2006
17. Maier SF, Watkins LR. Role of the medial prefrontal cortex in coping and
resilience. Brain Res (2010) 1355:52–60. doi:10.1016/j.brainres.2010.08.039
18. Miguel-Hidalgo J, Whittom A, Villarreal A, Soni M, Meshram A, Pickett J, et al.
Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex
in major depressive disorder. J Affect Disord (2014) 158:62–70. doi:10.1016/j.
jad.2014.02.010
19. Price J, Drevets W. Neurocircuitry of mood disorders.Neuropsychopharmacology
(2010) 35(1):192–216. doi:10.1038/npp.2009.104
20. Radley J, Anderson R, Hamilton B, Alcock J, Romig-Martin S. Chronic stress-
induced alterations of dendritic spine subtypes predict functional decrements
in an hypothalamo-pituitary-adrenal-inhibitory prefrontal circuit. J Neurosci
(2013) 33(36):14379–91. doi:10.1523/JNEUROSCI.0287-13.2013
21. Rajkowska G, Miguel-Hidalgo J, Wei J, Dilley G, Pittman S, Meltzer H, et al. Mor-
phometric evidence for neuronal and glial prefrontal cell pathology in major
depression. Biol Psychiatry (1999) 45(9):1085–98. doi:10.1016/S0006-3223(99)
00041-4
22. Murray PS, Holmes PV. An overview of brain-derived neurotrophic factor and
implications for excitotoxic vulnerability in the hippocampus. Int J Pept (2011)
2011:12. doi:10.1155/2011/654085
23. Stranahan A, Lee K, Martin B, Maudsley S, Golden E, Cutler R, et al. Volun-
tary exercise and caloric restriction enhance hippocampal dendritic spine den-
sity and BDNF levels in diabetic mice. Hippocampus (2009) 19(10):951–61.
doi:10.1002/hipo.20577
24. Vaynman S, Zing L, Gomez-Pinilla F. Interplay between BDNF and signal trans-
duction modulators in the regulation of the effects of exercise on synaptic plas-
ticity. Neuroscience (2003) 122:647–57. doi:10.1016/j.neuroscience.2003.08.001
25. Li Y, Luikart B, Birnbaum S, Chen J, Kwon C, Kernie S, et al. TrkB regulates
hippocampal neurogenesis and governs sensitivity to antidepressive treatment.
Neuron (2008) 59(3):399–412. doi:10.1016/j.neuron.2008.06.023
26. van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances neuroge-
nesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci U S A
(1999) 96(23):13427–31. doi:10.1073/pnas.96.23.13427

























































Holmes Exercise-induced stress resilience
27. Adlard P, Cotman C. Voluntary exercise protects against stress-induced decreases
in brain-derived neurotrophic factor protein expression. Neuroscience (2004)
124(4):985–92. doi:10.1016/j.neuroscience.2003.12.039
28. Neeper S, Gómez-Pinilla F, Choi J, Cotman C. Exercise and brain neurotrophins.
Nature (1995) 373(6510):109. doi:10.1038/373109a0
29. Duman C, Schlesinger L, Russell D, Duman R. Voluntary exercise produces
antidepressant and anxiolytic behavioral effects in mice. Brain Res (2008)
1199:148–58. doi:10.1016/j.brainres.2007.12.047
30. van Praag H. Neurogenesis and exercise: past and future directions. Neuromol-
ecular Med (2008) 10(2):128–40. doi:10.1007/s12017-008-8028-z
31. Groves J. Is it time to reassess the BDNF hypothesis of depression?Mol Psychiatry
(2007) 12(12):1079–88. doi:10.1038/sj.mp.4002075
32. Petrik D, Lagace D, Eisch A. The neurogenesis hypothesis of affective and anxiety
disorders: are we mistaking the scaffolding for the building? Neuropharmacology
(2012) 62(1):21–34. doi:10.1016/j.neuropharm.2011.09.003
33. Fuss J, Ben Abdallah NM, Hensley FW, Weber KJ, Hellweg R, Gass P. Dele-
tion of running-induced hippocampal neurogenesis by irradiation prevents
development of an anxious phenotype in mice. PLoS One (2010) 5(9):e12769.
doi:10.1371/journal.pone.0012769
34. Fuss J, Ben Abdallah NM, Vogt MA, Touma C, Pacifici PG, Palme R, et al.
Voluntary exercise induces anxiety-like behavior in adult C57BL/6 J mice
correlating with hippocampal neurogenesis. Hippocampus (2010) 20:364–76.
doi:10.1002/hipo.20634
35. Greenwood B, Strong P, Foley T, Thompson R, Fleshner M. Learned helpless-
ness is independent of levels of brain-derived neurotrophic factor in the
hippocampus. Neuroscience (2007) 144(4):1193–208. doi:10.1016/j.
neuroscience.2006.11.007
36. Hobson SA, Bacon A, Elliot-Hunt CR, Holmes FE, Kerr NC, Pope R, et al.
Galanin acts as a trophic factor to the central and peripheral nervous systems.
EXS (2010) 102:25–38. doi:10.1007/978-3-0346-0228-0_3
37. Hökfelt T, Tatemoto K. Galanin: a multitalented neuropeptide. EXS (2010)
102:1–5. doi:10.1007/978-3-0346-0228-0_1
38. Holmes PV, Crawley JN. Coexisting neurotransmitters in noradrenergic neu-
rons. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: The Fourth Gener-
ation of Progress. New York: Raven Press (1995). p. 347–53.
39. Hawes J, Picciotto M. Characterization of GalR1, GalR2, and GalR3 immunore-
activity in catecholaminergic nuclei of the mouse brain. J Comp Neurol (2004)
479(4):410–23. doi:10.1002/cne.20329
40. O’Donnell D, Ahmad S, Wahlestedt C, Walker P. Expression of the novel galanin
receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1.
J Comp Neurol (1999) 409(3):469–81. doi:10.1002/(SICI)1096-9861(19990705)
409:3<469::AID-CNE10>3.3.CO;2-H
41. Yoshitake S, Kuteeva E, Hökfelt T, Mennicken F, Theodorsson E, Yamaguchi M,
et al. Correlation between the effects of local and intracerebroventricular infu-
sions of galanin on 5-HT release studied by microdialysis, and distribution of
galanin and galanin receptors in prefrontal cortex, ventral hippocampus, amyg-
dala, hypothalamus, and striatum of awake rats. Synapse (2014) 68(5):179–93.
doi:10.1002/syn.21730
42. Sciolino NR, Dishman RK, Holmes PV. Voluntary exercise offers anxiolytic
potential and amplifies galanin gene expression in the locus coeruleus of the
rat. Behav Brain Res (2012) 233:191–200. doi:10.1016/j.bbr.2012.05.001
43. Murray PS, Groves JL, Pettett BJ, Britton SL, Koch LG, Dishman RK, et al.
Locus coeruleus galanin expression is enhanced after exercise in rats selec-
tively bred for high capacity for aerobic activity. Peptides (2010) 31:2264–8.
doi:10.1016/j.peptides.2010.09.005
44. Van Hoomissen JD, Holmes PV, Zellner AS, Poudevigne AM, Dishman RK. The
effect of B-adrenergic blockade during chronic exercise on contextual fear con-
ditioning and mRNA for galanin and brain-derived neurotrophic factor. Behav
Neurosci (2004) 118:1378–90. doi:10.1037/0735-7044.118.6.1378
45. Chambliss HO, Van Hoomissen JD, Holmes PV, Bunnell BN, Dishman RK.
Effects of chronic activity wheel running and imipramine on male copula-
tory behavior after olfactory bulbectomy. Physiol Behav (2004) 82:593–600.
doi:10.1016/j.physbeh.2004.04.064
46. Holmes PV, Yoo HS, Dishman RK. Voluntary exercise and clomipramine treat-
ment elevate prepro-galanin mRNA levels in the locus coeruleus in rats.Neurosci
Lett (2006) 408:1–4. doi:10.1016/j.neulet.2006.04.057
47. Karlsson RM, Holmes A. Galanin as a modulator of anxiety and depression
and a therapeutic target for affective disease. Amino Acids (2006) 31(3):231–9.
doi:10.1007/s00726-006-0336-8
48. Lu X, Ross B, Sanchez-Alavez M, Zorrilla E, Bartfai T. Phenotypic analysis of
GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neu-
ropeptides (2008) 42(4):387–97. doi:10.1016/j.npep.2008.04.009
49. Le Maître T, Xia S, Le Maitre E, Dun X, Lu J, Theodorsson E, et al. Galanin
receptor 2 overexpressing mice display an antidepressive-like phenotype: pos-
sible involvement of the subiculum. Neuroscience (2011) 190:270–88. doi:10.
1016/j.neuroscience.2011.05.015
50. Hobson S, Bacon A, Elliot-Hunt C, Holmes F, Kerr N, Pope R, et al. Galanin acts
as a trophic factor to the central and peripheral nervous systems. Cell Mol Life
Sci (2008) 65(12):1806–12. doi:10.1007/s00018-008-8154-7
51. Hobson S, Vanderplank P, Pope R, Kerr N, Wynick D. Galanin stimulates neurite
outgrowth from sensory neurons by inhibition of Cdc42 and Rho GTPases and
activation of cofilin. JNeurochem (2013) 127(2):199–208. doi:10.1111/jnc.12379
52. Chen Y, Kramár E, Chen L, Babayan A, Andres A, Gall C, et al. Impairment of
synaptic plasticity by the stress mediator CRH involves selective destruction of
thin dendritic spines via RhoA signaling. Mol Psychiatry (2013) 18(4):485–96.
doi:10.1038/mp.2012.17
53. Pirondi S, Fernandez M, Schmidt R, Hökfelt T, Giardino L, Calzà L. The
galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural
hippocampal cells. J Neurochem (2005) 95(3):821–33. doi:10.1111/j.1471-4159.
2005.03437.x
54. Koleske A. Molecular mechanisms of dendrite stability. Nat Rev Neurosci (2013)
14(8):536–50. doi:10.1038/nrn3486
55. Binder DK, Croll SD, Gall CM, Scharfman HE. BDNF and epilepsy: too much of
a good thing? Trends Neurosci (2001) 24(1):47–53. doi:10.1016/S0166-2236(00)
01682-9
56. Papaleo F, Silverman JL, Aney J, Tian Q, Barkan CL, Chadman KK, et al. Working
memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF
overexpressing mice. Learn Mem (2011) 18(8):534–44. doi:10.1101/lm.2213711
57. Scharfman HE, Goodman JH, Sollas AL, Croll SD. Spontaneous limbic seizures
after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neu-
rol (2002) 174:201–14. doi:10.1006/exnr.2002.7869
58. Ramsden M, Berchtold NC, Kesslak JP, Cotman CW, Pike CJ. Exercise increases
the vulnerability of rat hippocampal neurons to kainate lesion. Brain Res (2003)
971(2):239–44. doi:10.1016/S0006-8993(03)02365-5
59. Reiss JI, Dishman RK, Boyd H, Robinson JK, Holmes PV. Chronic activity
wheel running reduces the severity of kainic acid-induced seizures in the rat:
possible role of galanin. Brain Res (2009) 1266:54–63. doi:10.1016/j.brainres.
2009.02.030
60. Mazarati A, Langel U, Bartfai T. Galanin: an endogenous anticonvulsant? Neu-
roscientist (2001) 7(6):506. doi:10.1177/107385840100700607
61. Mazarati A, Lu X. Regulation of limbic status epilepticus by hippocampal
galanin type 1 and type 2 receptors. Neuropeptides (2005) 39(3):277–80.
doi:10.1016/j.npep.2004.12.003
62. Melander T, Hökfelt T, Rökaeus A, Cuello A, Oertel W, Verhofstad A,
et al. Coexistence of galanin-like immunoreactivity with catecholamines, 5-
hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci (1986)
6(12):3640–54.
63. Lu X, Sharkey L, Bartfai T. The brain galanin receptors: targets for novel
antidepressant drugs. CNS Neurol Disord Drug Targets (2007) 6(3):183–92.
doi:10.2174/187152707780619335
Conflict of Interest Statement: The author declares that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 21 May 2014; accepted: 14 July 2014; published online: 28 July 2014.
Citation: Holmes PV (2014) Trophic mechanisms for exercise-induced stress resilience:
potential role of interactions between BDNF and galanin. Front. Psychiatry 5:90. doi:
10.3389/fpsyt.2014.00090
This article was submitted to Affective Disorders and Psychosomatic Research, a section
of the journal Frontiers in Psychiatry.
Copyright © 2014 Holmes. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or repro-
duction in other forums is permitted, provided the original author(s) or licensor are
credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
www.frontiersin.org July 2014 | Volume 5 | Article 90 | 5
